3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Completed
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Gastrointestinal
1
Conditions
Glioblastoma
45
Neuroblastoma
16
Glioma
16
Brain Neoplasms
14
Astrocytoma
10
Neoplasms
8
Rhabdomyosarcoma
7
Sarcoma, Ewing
6
Recurrence
5
Oligodendroglioma
5
Medulloblastoma
5
Sarcoma
4
Osteosarcoma
4
Melanoma
4
Small Cell Lung Carcinoma
3
Neuroendocrine Tumors
3
Neuroectodermal Tumors, Primitive
3
Lymphoma
3
Gliosarcoma
3
Diffuse Intrinsic Pontine Glioma
3
Wilms Tumor
2
Rhabdoid Tumor
2
Pyloric Stenosis, Hypertrophic
2
Ovarian Neoplasms
2
Neoplasm Metastasis
2
Ganglioneuroblastoma
2
Fallopian Tube Neoplasms
2
Ependymoma
2
Colorectal Neoplasms
2
Central Nervous System Neoplasms
2
Interventions
Imatinib Mesylate
8
Sunitinib
3
ripretinib
2
regorafenib
2
apatinib
2
IDRX-42
2
trastuzumab deruxtecan
1
pemigatinib
1
olverembatinib
1
envafolimab
1
atezolizumab
1
Temozolomide
1
Surgical Instruments
1
Quality Assurance, Health Care
1
Paclitaxel
1
Observation
1
Neoadjuvant Therapy
1
Liquid Biopsy
1
Dasatinib
1
Blood Specimen Collection
1
4-Aminopyridine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Gastrointestinal Stromal Tumors
×
Temozolomide
×
Clear all
NCT05661643
2026-04-07
GIST
Asan Medical Center
Phase 2
Recruiting
29 enrolled